Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
Mais filtros

Medicinas Complementares
Intervalo de ano de publicação
1.
Future Microbiol ; 15: 1439-1452, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-33156698

RESUMO

Aim: This work aimed to develop a membrane based on voriconazole (VCZ)-loaded natural rubber latex (NRL) for treating infected ulcers with Candida spp. and study their interaction, drug release, antifungal activity against Candida parapsilosis and biological characterization. Materials & methods: VCZ-loaded NRL membrane was produced by casting method. Results: Infrared spectrum showed that the incorporation of VCZ into the NRL membrane maintained its characteristics. Its mechanical properties were considered suitable for dermal application. The VCZ was able to release from NRL membrane, maintaining its antifungal activity against C. parapsilosis, besides did not present hemolytic effects. Conclusion: The VCZ-NRL membrane showed good results in mechanical, antifungal and biological assays, representing an interesting alternative to treatment of infected wound with Candida spp.


Assuntos
Antifúngicos/farmacologia , Bandagens/microbiologia , Candida/efeitos dos fármacos , Látex/química , Úlcera Cutânea/microbiologia , Voriconazol/farmacologia , Antifúngicos/química , Fenômenos Biomecânicos , Candida/crescimento & desenvolvimento , Humanos , Testes de Sensibilidade Microbiana , Úlcera Cutânea/tratamento farmacológico , Voriconazol/química
2.
Fitoterapia ; 143: 104554, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32184096

RESUMO

Cypholophus macrocephalus sap is used to treat bacterially infected cutaneous leg ulcers in Papua New Guinea. High resolution LC-MS analysis of the sap revealed it to be rich in sulphated flavonoids. We assessed the effects of the sap on the differentiation and pro-inflammatory anti-microbial responses of M1 macrophages using IL-6 and TNF-α ELISAs and found significant increases in M1 macrophage IL-6 expression with concentrations as low as 243 ng/ml sap. Neutrophil IL-6 and TNF-α expression was also significantly increased but to a lesser degree. Matrix metalloproteinases (MMPs) 1, 2, 8 and 9 which are known to contribute to the toxic nature of wound exudates were inhibited by the sap at 24 µg/ml. The sap was tested with several bacterial species known to colonize cutaneous ulcers in Papua New Guinea but proved not to be active. Cypholophus sap stimulates pro-inflammatory, anti-microbial M1 macrophage and neutrophil responses at very low concentrations, whilst also inhibiting MMPs. The combination of an enhanced innate immune response and inhibition of MMPs in ulcer exudate, may contribute to the eradication of bacteria and healing of these infected ulcers. The sap concentrations used in these assays are readily achievable in an in vivo context.


Assuntos
Preparações de Plantas/uso terapêutico , Úlcera Cutânea/tratamento farmacológico , Urticaceae/química , Cicatrização , Adulto , Antibacterianos/farmacologia , Citocinas/metabolismo , Etnobotânica , Humanos , Macrófagos/efeitos dos fármacos , Inibidores de Metaloproteinases de Matriz/farmacologia , Metaloproteinases da Matriz/metabolismo , Testes de Sensibilidade Microbiana , Neutrófilos/efeitos dos fármacos , Papua Nova Guiné , Úlcera Cutânea/microbiologia , Adulto Jovem
4.
J Dermatol Sci ; 90(3): 323-331, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29534858

RESUMO

BACKGROUND: Pseudomonas aeruginosa (PA) frequently develops antibiotic-resistant characteristics, which is clinically problematic. The main reason behind the rise of antibiotic-resistant PA is the extensive use of antibiotics. Therefore, a novel technique is needed to treat PA infections. Photodynamic therapy (PDT) is thought to have the potential to be a non-antibiotic treatment for infections. 5-Aminolevulinic acid (ALA), which works as a photosensitizer after being metabolized into protoporphyrin IX (PpIX) in the heme synthetic pathway, is used for PDT. Thus far, the in vivo effectiveness of PDT using ALA against PA is unknown. OBJECTIVE: In this study, we investigated PDT using ALA both in vitro and in vivo. METHODS AND RESULTS: Although PDT with ALA alone did not show a bactericidal effect on PA, PDT with both ALA and EDTA-2Na had a bactericidal effect in vitro. In in vivo experiments, wounds healed faster in PA-infected mice treated with PDT using both EDTA-2Na and ALA compared to non-PDT. CONCLUSION: These results suggest that PDT with EDTA-2Na and ALA is a potential novel treatment option for PA-infected wounds.


Assuntos
Ácidos Levulínicos/uso terapêutico , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/uso terapêutico , Infecções por Pseudomonas/tratamento farmacológico , Pseudomonas aeruginosa/efeitos dos fármacos , Úlcera Cutânea/tratamento farmacológico , Administração Cutânea , Animais , Biofilmes/efeitos dos fármacos , Biofilmes/efeitos da radiação , Biópsia , Modelos Animais de Doenças , Ácido Edético/administração & dosagem , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Infecções por Pseudomonas/microbiologia , Infecções por Pseudomonas/patologia , Pseudomonas aeruginosa/fisiologia , Pseudomonas aeruginosa/efeitos da radiação , Pele/efeitos dos fármacos , Pele/microbiologia , Pele/patologia , Pele/efeitos da radiação , Úlcera Cutânea/microbiologia , Úlcera Cutânea/patologia , Cicatrização/efeitos dos fármacos , Cicatrização/efeitos da radiação , Ácido Aminolevulínico
5.
J Wound Care ; 27(Sup1): S20-S28, 2018 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-29334015

RESUMO

OBJECTIVE: Chronic wounds typically require several concurrent therapies, such as debridement, pressure offloading, and systemic and/or topical antibiotics. The aim of this study was to examine the efficacy of hyperbaric oxygen therapy (HBOT) towards reducing or eliminating bacterial biofilms in vitro and in vivo. METHOD: Efficacy was determined using in vitro grown biofilms subjected directly to HBOT for 30, 60 and 90 minutes, followed by cell viability determination using propidium monoazide-polymerase chain reaction (PMA-PCR). The efficacy of HBOT in vivo was studied by searching our chronic patient wound database and comparing time-to-healing between patients who did and did not receive HBOT as part of their treatment. RESULTS: In vitro data showed small but significant decreases in cell viability at the 30- and 90-minute time points in the HBOT group. The in vivo data showed reductions in bacterial load for patients who underwent HBOT, and ~1 week shorter treatment durations. Additionally, in patients' chronic wounds there was a considerable emergence of anaerobic bacteria and fungi between intermittent HBOT treatments. CONCLUSION: The data demonstrate that HBOT does possess a certain degree of biofilm killing capability. Moreover, as an adjuvant to standard treatment, more favourable patient outcomes are achieved through a quicker time-to-healing which reduces the chance of complications. Furthermore, the data provided insights into biofilm adaptations to challenges presented by this treatment strategy which should be kept in mind when treating chronic wounds. Further studies will be necessary to evaluate the benefits and mechanisms of HBOT, not only for patients with chronic wounds but other chronic infections caused by bacterial biofilms.


Assuntos
Biofilmes/efeitos dos fármacos , Oxigenoterapia Hiperbárica , Oxigênio/farmacologia , Úlcera Cutânea/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Enterococcus faecalis/efeitos dos fármacos , Enterococcus faecalis/genética , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/genética , Úlcera Cutânea/microbiologia , Úlcera Cutânea/enfermagem , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/genética , Fatores de Tempo , Resultado do Tratamento , Cicatrização
7.
Chin J Traumatol ; 20(4): 194-197, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28689800

RESUMO

PURPOSE: Skin ulcer is a common type of disease affecting patients' health and quality of life, and bacterial infection increases the difficulty of its management. METHODS: The present study collected the results of bacterial culture sampled from the surface of 110 cases of skin ulcers at our hospital from January 2011 to December 2012. We analyzed the constituent ratios of ulcer surface bacteria, the change in the main infectious bacteria and the results of drug-sensitivity testing for common bacteria. In addition, the characteristics of bacterial infection of skin ulcers were summarized. RESULT: Of the 110 samples, 90 isolated bacteria were cultured. Sixty-one were Gram-negative bacteria, mainly comprising Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter cloacae and Escherichia coli. In addition, 23 isolates were Gram-positive bacteria, mainly comprising Staphylococcus aureus and Enterococcus faecalis. The probability of a negative bacterial culture in 2012 was significantly lower than that in 2011 (16.7% vs. 40.0%, p < 0.01). Moreover, the probability of P. aeruginosa infection in 2012 was significantly higher than that in 2011 (31.7% vs. 14.0%, p < 0.01). P. aeruginosa was resistant to seven commonly used antibiotics. Both K. pneumoniae and E. coli had higher resistance to ampicillin. E. cloacae were not sensitive to piperacillin/tazobactam. Acinetobacter baumannii was resistant to all the tested drugs. S. aureus, E. faecalis and Staphylococcus epidermidis had high resistance to clindamycin. There was other drug resistance to reflect the higher rate of skin bacterial resistance. CONCLUSION: Skin bacterial resistance rate is high. Gram-negative bacteria gradually account for the majority, and P. aeruginosa becomes the most important skin infection pathogen. These characteristics of bacterial infections of skin ulcers provide a significant reference for guiding the selection of antibiotics, better controlling infections of skin ulcers and accelerating the healing of skin ulcers.


Assuntos
Antibacterianos/uso terapêutico , Bactérias/efeitos dos fármacos , Infecções Bacterianas/tratamento farmacológico , Úlcera Cutânea/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Farmacorresistência Bacteriana , Feminino , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Úlcera Cutânea/microbiologia , Adulto Jovem
8.
Lasers Med Sci ; 31(3): 549-56, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26886585

RESUMO

Low-level laser therapy (LLLT) is used in chronic wounds due to its healing effects. However, bacterial species may colonize these wounds and the optimal parameters for effective bacterial inhibition are not clear. The aim of this study was to analyze the effect of LLLT on bacterial growth in vitro. Bacterial strains including Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa were suspended in saline solution at a concentration of 10(3) cells/ml and exposed to laser irradiation at wavelengths of 660, 830, and 904 nm at fluences of 0 (control), 3, 6, 12, 18, and 24 J/cm(2). An aliquot of the irradiated suspension was spread on the surface of petri plates and incubated at 37 °C for quantification of colony-forming unit after 24, 48, and 72 h. Laser irradiation inhibited the growth of S. aureus at all wavelengths and fluences higher than 12 J/cm(2), showing a strong correlation between increase in fluence and bacterial inhibition. However, for P. aeruginosa, LLLT inhibited growth at all wavelengths only at a fluence of 24 J/cm(2). E. coli had similar growth inhibition at a wavelength of 830 nm at fluences of 3, 6, 12, and 24 J/cm(2). At wavelengths of 660 and 904 nm, growth inhibition was only observed at fluences of 12 and 18 J/cm(2), respectively. LLLT inhibited bacterial growth at all wavelengths, for a maximum of 72 h after irradiation, indicating a correlation between bacterial species, fluence, and wavelength.


Assuntos
Escherichia coli/efeitos da radiação , Terapia com Luz de Baixa Intensidade , Pseudomonas aeruginosa/efeitos da radiação , Úlcera Cutânea/microbiologia , Staphylococcus aureus/efeitos da radiação , Escherichia coli/fisiologia , Humanos , Raios Infravermelhos , Pseudomonas aeruginosa/fisiologia , Úlcera Cutânea/radioterapia , Staphylococcus aureus/fisiologia , Cicatrização
9.
Rev. esp. quimioter ; 27(3): 190-195, sept. 2014.
Artigo em Inglês | IBECS | ID: ibc-127594

RESUMO

To determine the prevalence and risk factors (RF) for methicillin-resistant Staphylococcus aureus (MRSA) during stay in 1 acute care hospital (ACH) and 4 long-term care facilities (LTCF). After obtaining the informed consent, nasal and skin ulcer swabs were taken and a survey was conducted to determine RF for MRSA. Six hundred and ninety nine patients were included, 413 LTCF and 286 ACH patients and MRSA prevalence were 22.5% and 7.3% respectively. MRSA was located in the nares, skin ulcers, and in both in 61.4%, 21.1%, and 17.5%. Among MRSA carriers, 81% of the ACH and 66.7% of the LTCF patients were only colonized. The multivariate analysis for the ACH revealed the following factors to be associated with MRSA: referral from an LTCF (OR 4.84), pressure ulcers (OR 4.32), a Barthel score < 60 (OR 2.60), and being male (OR 5.21). For the LTCF: urinary catheterisation (OR 3.53), pressure ulcers (OR 2.44), other skin lesions (OR 2.64), antibiotic treatment in ≤ 6 months, (OR 2.23), previous MRSA colonization (OR 2.15), and a Barthel score <20 (OR 1.28). Molecular typing identified 2 predominant clones Q, P, present in all centres. No relationship was found between clones and antibiotic susceptibility. In conclusion: MRSA prevalence is high in all centres but is 3 times greater in LTCF. The risk factors most strongly associated with MRSA were pressure ulcers and a stay in an LTCF. We propose preventive isolation in these cases (AU)


El objetivo de este estudio es determinar la prevalencia y factores de riesgo de Staphylococcus aureus resistente a meticilina (SARM) en 1 hospital de agudos y 4 centros socio sanitarios (CSS) de la misma área geográfica. Después de obtener el consentimiento informado de los pacientes se efectuó un frotis nasal y de úlceras cutáneas a los pacientes ingresados en las 5 instituciones. Al mismo tiempo se pasó un cuestionario para establecer los factores de riesgo de SARM. Se estudiaron 699 enfermos, 413 en los CSS y 286 en el hospital. La prevalencia de SARM en los CSS fue del 22,5% y del 7,3% en el hospital. Las localizaciones fueron nasal 61,4%, úlceras de decúbito 21,1% y ambas localizaciones 17,5%. El 81% de los portadores de SARM en el hospital y el 66,7% en los CSS estaban exclusivamente colonizados. El análisis multivariado en el hospital mostró que eran factores independientemente asociados a SARM: proceder de un CSS o residencia (OR 4,84), tener úlceras de decúbito (OR 4,32), un índice de Barthel <60 (OR 2,60) y ser varón (OR 5,21). En los CSS los factores independientemente asociados a SARM eran el sondaje urinario (OR 3,53), las úlceras de decúbito (OR 2,44) y otras lesiones cutáneas (OR 2,64), haber tomado antibióticos en los últimos 6 meses (OR 2,23), la colonización previa por SARM (OR 2,15) y un índice de Barthel < 20 (OR 1,28). Mediante tipificación molecular se han identificado 2 clones epidémicos predominantes Q y P distribuidos en todos los centros. No se ha observado relación entre los genotipos y la sensibilidad antibiótica. Conclusión: La prevalencia de SARM es alta en los 5 centros, siendo en los CSS tres veces superior a la del hospital. Las úlceras de decúbito y proceder de un CSS son los factores más fuertemente asociados a SARM por lo que proponemos que un aislamiento preventivo en estos pacientes (AU)


Assuntos
Humanos , Masculino , Feminino , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Staphylococcus aureus Resistente à Meticilina/metabolismo , Fatores de Risco , Doença Aguda/epidemiologia , Doença Aguda/terapia , Antibacterianos/uso terapêutico , Testes de Sensibilidade Microbiana , Sensibilidade e Especificidade , Resistência a Meticilina , Úlcera Cutânea/complicações , Úlcera Cutânea/diagnóstico , Úlcera Cutânea/microbiologia , Estudos Transversais
10.
G Ital Dermatol Venereol ; 149(3): 367-70, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24819766

RESUMO

Serratia marcescens is a species of gram negative bacillus, classified as a member of the Enterobacteriaceae, mainly involved in opportunistic infections, particulary in the hospital environment. Cutaneous infections have rarely reported in literature and are predominantly observed in elderly or in immunocompromised patients. The clinical manifestations of skin infections include granulomatous lesions, necrotizing fasciitis, nodules, cellulitis, ulcers, dermal abscesses. Infections caused by S. marcescens may be difficult to treat because of resistance to a variety of antibiotics, including ampicillin and first and second generation cephalosporins. Aminoglycosides have good activity against S. marcescens, but resistant strains have also been described. We report a very intriguing case of S. marcescens infection, in an immunocompetent 18-year-old man, causing multiple rounded ulcers of varying sizes, along with few pustular lesions that both clinically and histopathologically mimic a pyoderma gangrenosum (PG). This is a non infectious neutrophilic skin disorder, characterized by painful and rapidly progressing skin ulceration. According to our experience, we would strongly recommend to perform cultures of multiple skin ulcers resembling PG, even in young healthy patients, to ensure correct diagnosis and treatment, since resistant to conventional antibiotics bacteria such as S. marcescens may be the cause of these lesions, like in the case here reported.


Assuntos
Antibacterianos/uso terapêutico , Ciprofloxacina/uso terapêutico , Imunocompetência , Infecções por Serratia/diagnóstico , Infecções por Serratia/tratamento farmacológico , Serratia marcescens/isolamento & purificação , Úlcera Cutânea/tratamento farmacológico , Úlcera Cutânea/microbiologia , Adolescente , Diagnóstico Diferencial , Humanos , Masculino , Pioderma Gangrenoso/diagnóstico , Infecções por Serratia/complicações , Úlcera Cutânea/diagnóstico , Resultado do Tratamento
11.
Intern Med ; 52(6): 689-93, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23503412

RESUMO

Infection with Scedosporium apiospermum (S. apiospermum) is rare, although it is associated with a high fatality rate, especially in immunosuppressed patients. A 23-year-old man with acute myelogenous leukemia (AML) (M2) who was pretreated with chemotherapy for autologous bone marrow transplantation developed a skin ulcer on the left groin. After a culture study demonstrated the presence of S. apiospermum, voriconazole was administered and the lesion rapidly improved. Since a diagnosis of S. apiospermum continues to depend on the results of a fungal culture and most isolates of S. apiospermum are resistant to amphotericin B, voriconazole should be considered as the first choice when "mold" is thought to be the causative organism.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Transplante de Medula Óssea , Dermatomicoses/etiologia , Imunossupressores/efeitos adversos , Infecções Oportunistas/etiologia , Complicações Pós-Operatórias/microbiologia , Scedosporium/isolamento & purificação , Úlcera Cutânea/etiologia , Antifúngicos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Terapia Combinada , Citarabina/administração & dosagem , Daunorrubicina/administração & dosagem , Dermatomicoses/tratamento farmacológico , Dermatomicoses/microbiologia , Medicamentos de Ervas Chinesas/uso terapêutico , Humanos , Hospedeiro Imunocomprometido , Leucemia Mieloide Aguda/tratamento farmacológico , Leucemia Mieloide Aguda/cirurgia , Masculino , Mitoxantrona/administração & dosagem , Infecções Oportunistas/tratamento farmacológico , Infecções Oportunistas/microbiologia , Complicações Pós-Operatórias/tratamento farmacológico , Pirimidinas/uso terapêutico , Úlcera Cutânea/tratamento farmacológico , Úlcera Cutânea/microbiologia , Condicionamento Pré-Transplante , Transplante Autólogo , Triazóis/uso terapêutico , Voriconazol , Adulto Jovem
12.
Zhongguo Zhong Yao Za Zhi ; 37(6): 711-4, 2012 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-22715705

RESUMO

OBJECTIVE: To compare the effects of Badu Shengji San (BDSJS) on rats with different injured skins. METHOD: The injured and ulcerous skin rat model was established to observe the renal injury induced by BDSJS, a mercury-containing external preparation of Chinese medicine, with urinary N-acetyl-beta-D-glucosaminidase (NAG) and retinol binding protein (RBP) as indicators of renal toxicity. RESULT: Compared to injured skin rats with the same dose, both of high and low-dose ulcerous skin groups showed obvious increase in urinary RBP and kidney coefficients, significant pathomorphological changes in renal tubules and notable epithelial cytopathic effects. In terms of NAG, the high-dose ulcerous skin group saw no significant increase, but the low-dose group recorded sharp rise. CONCLUSION: The renal toxicity induced by BDSJS in ulcerous skin rats was more toxic than that in injured skin ones.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Túbulos Renais/efeitos dos fármacos , Mercúrio/toxicidade , Úlcera Cutânea/tratamento farmacológico , Pele/efeitos dos fármacos , Infecções Cutâneas Estafilocócicas/tratamento farmacológico , Acetilglucosaminidase/urina , Animais , Modelos Animais de Doenças , Medicamentos de Ervas Chinesas/uso terapêutico , Medicamentos de Ervas Chinesas/toxicidade , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Túbulos Renais/metabolismo , Túbulos Renais/patologia , Masculino , Mercúrio/urina , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Proteínas de Ligação ao Retinol/urina , Pele/lesões , Úlcera Cutânea/microbiologia
13.
Zhongguo Zhong Yao Za Zhi ; 37(6): 735-8, 2012 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-22715711

RESUMO

OBJECTIVE: To study the effect of repeated administration of Zhuhong ointment on renal antioxidant capability of ulcerous skin in rats, in order to further discuss the mechanism of mercury contained in Zhuhong ointment on the antioxidant capability of kidney in skin ulcer rats. METHOD: Eighty SD rats were randomly divided into eight groups: Zhuhong ointment A, B, C, D, E (1.219, 0.609, 0.305, 0.152, 0.76 g x kg(-1)) groups, the vaseline group, the ulcer model group and the impairment control group. The levels of NAG and RBP of toxicity for early kidney tubular injury and T-AOC, SOD, GSH-PX and GSH in kidney were determined after consecutive administration for 14 days. RESULT: Compared with ulcer model group, the levels of RBP in groups A, B, C and D increased, while the levels of NAG increased only in the group A. The level of T-AOC increased in groups A, B and C. The level of T-SOD increased in the group E, while it dropped down greatly in the group A. The level of GSH-PX increased in groups A, B and C. The content of GSH increased in every dose groups. CONCLUSION: Antioxidant capacity in rats can be increased in a reasonable dose of Zhuhong ointment, but some antioxidant activity can be notably inhibited by with the increase of dose.


Assuntos
Antioxidantes/metabolismo , Medicamentos de Ervas Chinesas/farmacologia , Túbulos Renais/efeitos dos fármacos , Mercúrio/metabolismo , Úlcera Cutânea/metabolismo , Infecções Cutâneas Estafilocócicas/metabolismo , Acetilglucosaminidase/efeitos dos fármacos , Acetilglucosaminidase/urina , Animais , Antioxidantes/análise , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/toxicidade , Glutationa/efeitos dos fármacos , Glutationa/metabolismo , Glutationa Peroxidase/efeitos dos fármacos , Glutationa Peroxidase/metabolismo , Túbulos Renais/lesões , Túbulos Renais/metabolismo , Masculino , Pomadas , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Proteínas de Ligação ao Retinol/efeitos dos fármacos , Proteínas de Ligação ao Retinol/urina , Úlcera Cutânea/microbiologia , Organismos Livres de Patógenos Específicos , Superóxido Dismutase/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Fatores de Tempo
14.
Rural Remote Health ; 10(4): 1485, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21073252

RESUMO

INTRODUCTION: Tuberculosis (TB), which is endemic in developing countries, is an important public health problem. Cutaneous TB (CT) represents 1.5% of all TB cases and is considered to be a re-emerging pathology in developing countries due to co-infections with HIV, multidrug-resistant TB, a shortage of health facilities with appropriate diagnostic equipment, reduced access to treatment, and poor treatment compliance among patients who often resort to traditional medicine. CASE REPORT: This report describes the case of a 70 year-old woman who attended the outpatients department of the Italian Dermatological Centre (IDC) in Mekelle, the capital city of Tigray (Northern Ethiopia), complaining of the appearance of two ulcers on her face and neck. The patient had a history of pulmonary TB, with her initial systemic treatment ceased after 1 month. Cytological examination of a needle aspiration from the neck lesion showed a non-specific bacterial superinfection. No acid-fast bacilli were found on Ziehl-Nielsen staining. On the basis of clinical suspicion of CT, it was decided to avoid biopsy for histology and culture and to immediately start anti-tubercular treatment. A significant improvement of the cutaneous lesions was noted after approximately 40 days. CONCLUSION: Currently, the diagnosis of CT is based on careful clinical and histopathological correlation. The standard diagnostic approach is to biopsy for Ziehl-Nielsen stain, culture and histology. However, in rural areas of DC where diagnostic methods may not be available and advanced stages of disease such as CT are likely to be encountered, after the use of the most effective diagnostic tests available, empirical treatment on the basis of medical history and physical examination is suggested. Appropriate training of healthcare workers and public health education programs encouraging early presentation and improved patient treatment compliance are additional important preventative strategies.


Assuntos
Pescoço/microbiologia , Úlcera Cutânea/microbiologia , Tuberculose Cutânea/diagnóstico , Idoso , Antituberculosos/uso terapêutico , Etiópia , Feminino , Humanos , Serviços de Saúde Rural , Tuberculose Cutânea/tratamento farmacológico , Tuberculose Pulmonar
15.
N Z Med J ; 123(1312): 61-7, 2010 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-20389319

RESUMO

We present a patient with locally advanced squamous cell carcinoma that had grown significantly during 16 months of intensive alternative therapy. The alternative medicine practitioner allegedly repeatedly reassured the patient that her condition was benign and advised against seeking conventional medical treatment. Due to the delayed presentation, the patient required extensive surgery and postoperative adjuvant radiotherapy. This case highlights the risks of alternative therapy in the place of proven conventional medical treatment and emphasises the limitations of current regulation of complementary and alternative medicine in New Zealand.


Assuntos
Carcinoma de Células Escamosas/diagnóstico , Terapias Complementares/legislação & jurisprudência , Erros de Diagnóstico , Neoplasias Cutâneas/diagnóstico , Idoso , Anemia Macrocítica/diagnóstico , Carcinoma de Células Escamosas/terapia , Diagnóstico Tardio , Dura-Máter/patologia , Feminino , Hemoglobinas/análise , Humanos , Contagem de Leucócitos , Invasividade Neoplásica , Nova Zelândia , Radioterapia Adjuvante , Couro Cabeludo/patologia , Couro Cabeludo/cirurgia , Neoplasias Cutâneas/terapia , Úlcera Cutânea/microbiologia , Úlcera Cutânea/patologia , Crânio/patologia
16.
Actas Dermosifiliogr ; 101(2): 188-90, 2010 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-20223169
17.
Br J Nurs ; 18(15): S30, S32-6, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19717999

RESUMO

This article uses a case study approach to demonstrate good clinical outcomes using a bacterial binding dressing range on a variety of difficult wounds. A case study approach can demonstrate a clinician's perspective on the practicalities of dressing choice in practice. All wounds, whether acute or chronic, offer pathogenic micro-organisms the opportunity to flourish - this can result in slow healing. Antimicrobial dressings use active ingredients but the Cutimed Sorbact range is a bacterial binding wound dressing that offers an alternative approach to the management of bio-burden. All dressings have a cost implication and holistic wound assessment is the key to accurate diagnosis and treatment, as well as directing the practitioner to an appropriate management strategy.


Assuntos
Anti-Infecciosos/administração & dosagem , Infecções Bacterianas/tratamento farmacológico , Infecções Bacterianas/enfermagem , Curativos Oclusivos , Úlcera Cutânea/enfermagem , Úlcera Cutânea/terapia , Adolescente , Adulto , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Úlcera Cutânea/microbiologia , Cicatrização/efeitos dos fármacos
18.
Dermatol Ther ; 21 Suppl 3: S26-8, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19076628

RESUMO

Calciphylaxis or calcific uremic arteriolopathy is characterized by the involvement of the tunica elastica of the reticular or deep subcutaneous dermis, with extravascular and vascular thrombosis calcifications that lead to tissular ischemia. The torso muscles, the lumbar region, and lower limbs are more frequently affected. The pathogenesis is unknown. Calciphylaxis is associated to hyperparathyroidism, chronic renal failure, and diabetes mellitus. The best therapy to date is prevention: early treatment of renal failure, performing a partial parathyroidectomy where necessary, surgical debridement of the necrotic tissue, as well as avoiding the trigger factors such as systemic corticosteroids.


Assuntos
Calciofilaxia/etiologia , Falência Renal Crônica/complicações , Úlcera Cutânea/etiologia , Idoso , Antibacterianos/uso terapêutico , Anticoagulantes/uso terapêutico , Biópsia , Calciofilaxia/sangue , Calciofilaxia/microbiologia , Calciofilaxia/patologia , Calciofilaxia/terapia , Cálcio/sangue , Terapia Combinada , Desbridamento , Evolução Fatal , Humanos , Falência Renal Crônica/terapia , Masculino , Tratamento de Ferimentos com Pressão Negativa , Hormônio Paratireóideo/sangue , Fósforo/sangue , Diálise Renal , Sepse/etiologia , Úlcera Cutânea/sangue , Úlcera Cutânea/microbiologia , Úlcera Cutânea/patologia , Úlcera Cutânea/terapia , Retalhos Cirúrgicos/efeitos adversos
19.
Adv Skin Wound Care ; 21(11): 531-40; quiz 541-2, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18981758

RESUMO

PURPOSE: To provide the wound care practitioner with a review of the assessment and management of chronic wound infection. TARGET AUDIENCE: This continuing education activity is intended for physicians and nurses with an interest in skin and wound care. OBJECTIVES: After reading this article and taking this test, the reader should be able to: 1. Discuss the etiology of chronic wounds. 2. Describe the agents used for the treatment of chronic wound infections.


Assuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Farmacorresistência Bacteriana , Cicatrização/efeitos dos fármacos , Infecção dos Ferimentos/tratamento farmacológico , Anti-Infecciosos Locais/uso terapêutico , Bactérias Anaeróbias/efeitos dos fármacos , Bactérias Anaeróbias/isolamento & purificação , Infecções Bacterianas/microbiologia , Doença Crônica , Desinfetantes/uso terapêutico , Resistência a Múltiplos Medicamentos , Feminino , Seguimentos , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Negativas/isolamento & purificação , Bactérias Gram-Positivas/efeitos dos fármacos , Bactérias Gram-Positivas/isolamento & purificação , Humanos , Masculino , Testes de Sensibilidade Microbiana , Medição de Risco , Índice de Gravidade de Doença , Úlcera Cutânea/tratamento farmacológico , Úlcera Cutânea/microbiologia , Resultado do Tratamento , Cicatrização/fisiologia , Infecção dos Ferimentos/microbiologia , Infecção dos Ferimentos/fisiopatologia
20.
Am J Clin Dermatol ; 9(6): 399-403, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18973408

RESUMO

Mycoplasma pneumoniae-associated mucositis is a rarely described complication of M. pneumoniae infection presenting with ocular, oral, and genital involvement but without the typical skin lesions seen in Stevens-Johnson syndrome. A 27-year-old man with a past history of asthma presented at the emergency room with a 1-week history of cough (initially non-productive but subsequently associated with non-bloody mucopurulent sputum), fever, myalgias, headache, and progressive dyspnea. Two days before admission he had commenced amoxicillin/clavulanic acid with no improvement. The patient reported bilateral conjunctival injection and hemorrhagic ulcers on the lips commencing the day prior to admission. Physical examination revealed fever (39 degrees C), bilateral exudative conjunctivitis, painful hemorrhagic ulcers on the lips, tongue, and oral mucosa, small scrotal erosions, erythema of the penile meatus, and small erythematous bullae on the dorsum of each hand; subsequently, the patient developed bullae at the venipuncture site on his right arm. Laboratory tests revealed positive IgM serology for M. pneumoniae, with titer elevation. The patient was successfully treated with levofloxacin and prednisolone. Our case appears to be the first adult patient described with M. pneumoniae-associated mucositis, which has previously been reported only in pediatric patients. This is also the first reported instance of a case of M. pneumoniae-associated mucositis treated with levofloxacin and prednisolone. M. pneumoniae infection should be considered in all cases of mucositis, and treatment of this condition with levofloxacin and prednisolone seems to be effective.


Assuntos
Levofloxacino , Mucosite/patologia , Infecções por Mycoplasma/patologia , Mycoplasma pneumoniae/isolamento & purificação , Ofloxacino/uso terapêutico , Adulto , Antibacterianos/uso terapêutico , Asma/complicações , Conjuntivite/microbiologia , Humanos , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Pulmão/patologia , Masculino , Mucosite/tratamento farmacológico , Infecções por Mycoplasma/tratamento farmacológico , Prednisolona/uso terapêutico , Radiografia Torácica , Úlcera Cutânea/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA